FDA Inspection
Charles Redfern, MDCharles Redfern, MD – FDA Inspection, Mar 11, 2022
Record Details
This FDA Inspection record concerns Charles Redfern, MD, with an inspection on March 11, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Charles Redfern, MD
- Inspection Date
- March 11, 2022
- Product Type
- Drugs
View Company Profile
ID · 26055cd1-48f3-43ae-a26c-09fa5e6af339
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1164669
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Charles Redfern, MD
1| Date | Classification | Office | Project area |
|---|---|---|---|
| January 15, 2010 | VAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
Other documents for Charles Redfern, MD
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.